Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

Inclusion Criteria: * Males or Females 12 years of age or older with a diagnosis of mild to moderate acne vulgaris. * Subjects must sign written informed consent and agree to come for all study visits. Exclusion Criteria: * Use of experimental drugs within 1 month prior to initiation of study therapy. * Pregnant and nursing females will not be allowed in the study, and females of childbearing potential will have a pregnancy test at baseline. Females of childbearing potential must agree to use approved birth control methods for the duration of the study. * Use of systemic retinoids within 2 months of enrollment, use of any topical retinoids, systemic antibiotics, nicotinamide, systemic steroids or any other medication that may confound the results of the study within 1 month prior to start of the study * Use of any other topical medications for acne, including cosmetics containing retinol, within 2 weeks prior to study entry. * Any skin condition or disease that may require concurrent therapy or may confound the evaluation; * History of hypersensitivity to any of the formulation components; * Facial skin cancer or facial actinic keratosis; * Use of any photosensitizing agents. * Use of isotretinoin within the last 6 months. * Chemical peels, microdermabrasion or laser resurfacing within 3 months of study entry. * Crohns disease, ulcerative colitis, or have developed colitis with past antibiotic use.